Prostate cancer (PCa) is the most common male‐specific cancer and its worldwide incidence is rising1 largely due to increased prostate specific antigen (PSA) and multi‐parametric magnetic resonance imaging (mpMRI) utilisation in an ageing population. The gene discussed is KLK3; the disease is posterior cortical atrophy.